This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
A furan-containing insurmountable antagonist and inverse agonist of the adenosine A2A receptor for Parkinson’s disease. Kyowa Kirin’s KW-6356, or sipagladenant,…
molecule
1 month ago ●
8 mins read
At AAPS 2022, I hosted a symposium where Ovoca Bio plc's Head of Research, Mikhail Lomonosov told us about orenetide.…
Article
7 months ago ●
3 mins read
A Treg-modulating IKZF2 (Helios) glue degrader for cancer immunotherapy. Tumors can evade the immune system through the recruitment of regulatory…
molecule
1 month ago ●
7 mins read
Drug candidates exhibiting atropisomerism are often considered challenging for development by pharmaceutical professionals from synthetic and regulatory perspectives. Molecules that…
Article
7 months ago ●
5 mins read
ACT-777991: next-generation CXCR3 antagonist in Phase I trials for Type 1 diabetes. ACT-777991, an oral and insurmountable CXCR3 antagonist discovered…
molecule
3 weeks ago ●
11 mins read
No time to research ideas before your next team meeting? Grab a coffee and check out these key molecules. Click…
Article
7 months ago ●
1 min read
Load More
